nodes	percent_of_prediction	percent_of_DWPC	metapath
Moxifloxacin—TOP2A—G0 and Early G1—E2F5—ocular cancer	0.0478	0.0478	CbGpPWpGaD
Moxifloxacin—TOP2A—G0 and Early G1—E2F4—ocular cancer	0.0468	0.0468	CbGpPWpGaD
Moxifloxacin—TOP2A—G0 and Early G1—MYBL2—ocular cancer	0.0468	0.0468	CbGpPWpGaD
Moxifloxacin—TOP2A—G0 and Early G1—RBL1—ocular cancer	0.0459	0.0459	CbGpPWpGaD
Moxifloxacin—TOP2A—G0 and Early G1—RBL2—ocular cancer	0.0421	0.0421	CbGpPWpGaD
Moxifloxacin—TOP2A—Gastric Cancer Network 1—MYBL2—ocular cancer	0.0416	0.0416	CbGpPWpGaD
Moxifloxacin—TOP2A—G0 and Early G1—RBBP4—ocular cancer	0.0398	0.0398	CbGpPWpGaD
Moxifloxacin—TOP2A—G0 and Early G1—CDC25A—ocular cancer	0.0378	0.0378	CbGpPWpGaD
Moxifloxacin—TOP2A—G0 and Early G1—TFDP1—ocular cancer	0.037	0.037	CbGpPWpGaD
Moxifloxacin—TOP2A—G0 and Early G1—HDAC1—ocular cancer	0.0215	0.0215	CbGpPWpGaD
Moxifloxacin—TOP2A—G0 and Early G1—E2F1—ocular cancer	0.0177	0.0177	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—E2F2—ocular cancer	0.0169	0.0169	CbGpPWpGaD
Moxifloxacin—TOP2A—G0 and Early G1—CDK2—ocular cancer	0.0152	0.0152	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2C—ocular cancer	0.0149	0.0149	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RBBP4—ocular cancer	0.0147	0.0147	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—E2F3—ocular cancer	0.0147	0.0147	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDC25A—ocular cancer	0.014	0.014	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TFDP1—ocular cancer	0.0136	0.0136	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—E2F5—ocular cancer	0.0124	0.0124	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND3—ocular cancer	0.0124	0.0124	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—E2F4—ocular cancer	0.0121	0.0121	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—MYBL2—ocular cancer	0.0121	0.0121	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—E2F2—ocular cancer	0.0119	0.0119	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—RBL1—ocular cancer	0.0119	0.0119	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—RBL2—ocular cancer	0.0109	0.0109	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—CRTC1—ocular cancer	0.0108	0.0108	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—E2F3—ocular cancer	0.0103	0.0103	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—RBBP4—ocular cancer	0.0103	0.0103	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDC25A—ocular cancer	0.00982	0.00982	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—ID2—ocular cancer	0.00966	0.00966	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—TFDP1—ocular cancer	0.0096	0.0096	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK6—ocular cancer	0.00921	0.00921	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.0092	0.0092	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.00902	0.00902	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CCND3—ocular cancer	0.0087	0.0087	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—HDAC1—ocular cancer	0.00792	0.00792	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—E2F1—ocular cancer	0.00652	0.00652	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDK6—ocular cancer	0.00648	0.00648	CbGpPWpGaD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—ocular cancer	0.00645	0.00645	CbGpPWpGaD
Moxifloxacin—TOP2A—Gastric Cancer Network 2—MYC—ocular cancer	0.00628	0.00628	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK2—ocular cancer	0.00562	0.00562	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CCND2—ocular cancer	0.00558	0.00558	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—HDAC1—ocular cancer	0.00558	0.00558	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2C—ocular cancer	0.00546	0.00546	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—ocular cancer	0.00531	0.00531	CbGpPWpGaD
Moxifloxacin—TOP2A—Gastric Cancer Network 2—TP53—ocular cancer	0.00516	0.00516	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2B—ocular cancer	0.005	0.005	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CDKN2C—ocular cancer	0.00488	0.00488	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—GNA11—ocular cancer	0.00484	0.00484	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RB1—ocular cancer	0.00462	0.00462	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—E2F1—ocular cancer	0.00459	0.00459	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—E2F5—ocular cancer	0.00455	0.00455	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—GNAQ—ocular cancer	0.0045	0.0045	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—E2F4—ocular cancer	0.00445	0.00445	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—MYBL2—ocular cancer	0.00445	0.00445	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—E2F2—ocular cancer	0.00437	0.00437	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—RBL1—ocular cancer	0.00437	0.00437	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—E2F5—ocular cancer	0.00406	0.00406	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—HDAC1—ocular cancer	0.00405	0.00405	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—RBL2—ocular cancer	0.00401	0.00401	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—E2F4—ocular cancer	0.00398	0.00398	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—MYBL2—ocular cancer	0.00398	0.00398	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDK2—ocular cancer	0.00396	0.00396	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—ocular cancer	0.00394	0.00394	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—E2F2—ocular cancer	0.00391	0.00391	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—RBL1—ocular cancer	0.00391	0.00391	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—E2F3—ocular cancer	0.00379	0.00379	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—RBBP4—ocular cancer	0.00379	0.00379	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.00379	0.00379	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDK4—ocular cancer	0.00374	0.00374	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDC25A—ocular cancer	0.0036	0.0036	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—ocular cancer	0.0036	0.0036	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—RBL2—ocular cancer	0.00359	0.00359	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—TFDP1—ocular cancer	0.00352	0.00352	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.00348	0.00348	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—ocular cancer	0.00343	0.00343	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—E2F3—ocular cancer	0.00339	0.00339	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—RBBP4—ocular cancer	0.00339	0.00339	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—ocular cancer	0.00332	0.00332	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—RB1—ocular cancer	0.00325	0.00325	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CDC25A—ocular cancer	0.00322	0.00322	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CCND3—ocular cancer	0.00319	0.00319	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—TFDP1—ocular cancer	0.00315	0.00315	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.003	0.003	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CCND3—ocular cancer	0.00285	0.00285	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.00283	0.00283	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—ocular cancer	0.00275	0.00275	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—CDK4—ocular cancer	0.00272	0.00272	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—ocular cancer	0.00253	0.00253	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—ocular cancer	0.00241	0.00241	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDK6—ocular cancer	0.00238	0.00238	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1A—ocular cancer	0.00234	0.00234	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—ocular cancer	0.00226	0.00226	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CDK6—ocular cancer	0.00213	0.00213	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.0021	0.0021	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CCND2—ocular cancer	0.00204	0.00204	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—HDAC1—ocular cancer	0.00204	0.00204	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—ocular cancer	0.00194	0.00194	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.00192	0.00192	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2B—ocular cancer	0.00183	0.00183	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.00183	0.00183	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CCND2—ocular cancer	0.00183	0.00183	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—HDAC1—ocular cancer	0.00183	0.00183	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.00177	0.00177	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.00168	0.00168	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—E2F1—ocular cancer	0.00168	0.00168	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CDKN2B—ocular cancer	0.00164	0.00164	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—EP300—ocular cancer	0.00162	0.00162	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—E2F1—ocular cancer	0.0015	0.0015	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.00147	0.00147	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.00146	0.00146	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDK2—ocular cancer	0.00145	0.00145	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDK4—ocular cancer	0.00137	0.00137	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CDK2—ocular cancer	0.0013	0.0013	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CDK4—ocular cancer	0.00123	0.00123	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.00121	0.00121	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—RB1—ocular cancer	0.00119	0.00119	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—TP53—ocular cancer	0.00116	0.00116	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—RB1—ocular cancer	0.00107	0.00107	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.00102	0.00102	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—ocular cancer	0.000928	0.000928	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—MDM2—ocular cancer	0.000909	0.000909	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—ocular cancer	0.000886	0.000886	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1A—ocular cancer	0.000857	0.000857	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CDKN1B—ocular cancer	0.00083	0.00083	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—EP300—ocular cancer	0.000815	0.000815	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CCND1—ocular cancer	0.000792	0.000792	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CDKN1A—ocular cancer	0.000766	0.000766	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—EP300—ocular cancer	0.000729	0.000729	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—MYC—ocular cancer	0.00071	0.00071	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—MYC—ocular cancer	0.000635	0.000635	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—TP53—ocular cancer	0.000522	0.000522	CbGpPWpGaD
